Life Sciences Health (LSH) is the national cluster organization of the Dutch life sciences & health sector.
We strive to utilize the sector’s potential to the utmost, enabling patients and society to benefit from its excellent position in research and healthcare.
Our point of departure is the value of its activities for businesses, more specifically, small and medium sized enterprises (SMEs).
Our goal: a healthy life sciences and health sector where we all benefit from.
-
-
Listen to keynote speaker Désiré Collen at the Dutch Life Sciences Health conference, December 13, 2011.
Désiré Collen is Chief Executive Officer and Chairman ThromboGenics.
Interested in what other life sciences pro's have to say? Listen to their kennisclips.
-
Collaboration, innovation and commercialization propel new medicines and diagnostics to patients. Leveraging MassBio’s network of world-class talent through our programs, we facilitate the translation of early stage technologies to products that meet patient needs.
Tap into MassBio’s network through the MassBio Innovation Exchange.
-
Life sciences & health company profiles
Download the company profile book: more than 80 Dutch biotech companies at your fingertips.
Your company in the company profile book?E-mail info[at]lifescienceshealth[dot]com for more information.
Upcoming events
Click here for the Niaba agenda (in dutch).
Latest news from LSH
